J Clin Oncol 23 (31): 7794-803, 2005.[PUBMED Abstract] Ibrahim NK, Samuels B, Page R, et al.: Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer.
J Clin Oncol 23 (25): 6019-26, 2005.[PUBMED Abstract] Blum JL, Jones SE, Buzdar AU, et al.: Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.
J Clin Oncol 17 (2): 485-93, 1999.[PUBMED Abstract] Blum JL, Dieras V, Lo Russo PM, et al.: Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients.
Cancer 92 (7): 1759-68, 2001.[PUBMED Abstract] Venturini M, Paridaens R, Rossner D, et al.: An open-label, multicenter study of outpatient capecitabine monotherapy in 631 patients with pretreated advanced breast cancer.